Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF-108 and PRF-110 in Experimental Pain Model
NCT00883194Phase 2Completed
- Sponsor
- PainReform
- Start
- Oct 2010
- Primary completion
- Apr 2011
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PRF-108 and PRF-110 in pain (4 arms), sponsored by PainReform. Primary endpoint: Duration of analgesia at 3 days. Started Oct 2010; status: completed.
02
Drugs
PRF-108PRF-110
03
Conditions
pain
Beyond the preview
Go deeper on NCT00883194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00883194.